In this study, we investigated the expression and function of ARL5B in retinoblastoma and further explored the underlying mechanisms, providing an experimental basis for the clinical application of RPL41 and identifying a new target for the treatment of retinoblastoma. Here, RPL41 is linked to retinoblastoma.